Carregant...

Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats

BACKGROUND: Treatment with metformin, the biguanide of hepatic insulin sensitizer, in patients with non-alcoholic fatty liver disease (NAFLD) has been reported with contradictory findings regarding the effectiveness on blood lipids and liver histology. In this study, we aimed to explore the preventi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetol Metab Syndr
Autors principals: Sui, Yi, Kong, Xianhe, Fan, Rongrong, Ye, Yanbin, Mai, Haiyan, Zhuo, Shuyu, Lu, Wei, Ruan, Peishan, Fang, Shi, Yang, Tao
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6852932/
https://ncbi.nlm.nih.gov/pubmed/31749893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-019-0491-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!